Kodiak Sciences (KOD) Other Non-Current Liabilities (2017 - 2026)
Kodiak Sciences (KOD) reported Other Non-Current Liabilities of $100.0 million for Q1 2026, little changed on a YoY basis from $100.0 million in Q1 2025, and little changed quarter-over-quarter from $100.0 million in Q4 2025.
Kodiak Sciences (KOD) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends
Kodiak Sciences has reported Other Non-Current Liabilities for 10 years, with the latest figure at $100.0 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities changed 0.0% year-over-year to $100.0 million; the trailing twelve-month figure through Mar 2026 stood at $100.0 million (changed 0.0% YoY), and the FY2025 full-year result was $100.0 million, changed 0.0% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $100.0 million, roughly flat from $100.0 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $100.0 million in Q1 2023, with the low at $162000.0 in Q4 2022.
- Historically, Other Non-Current Liabilities has averaged $87.5 million across 5 years, with a median of $100.0 million in 2023.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities sank 99.82% — and 2023, when it jumped 61628.4%.
- Kodiak Sciences' Other Non-Current Liabilities stood at $162000.0 in 2022, then jumped by 61628.4% to $100.0 million in 2023, then changed by 0.0% to $100.0 million in 2024, then changed by 0.0% to $100.0 million in 2025, then changed by 0.0% to $100.0 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $100.0 million (Q1 2026), $100.0 million (Q4 2025), and $100.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.00 Mn |
| Dec 31, 2025 | 100.00 Mn |
| Sep 30, 2025 | 100.00 Mn |
| Jun 30, 2025 | 100.00 Mn |
| Mar 31, 2025 | 100.00 Mn |
| Dec 31, 2024 | 100.00 Mn |
| Sep 30, 2024 | 100.00 Mn |
| Jun 30, 2024 | 100.00 Mn |
| Mar 31, 2024 | 100.00 Mn |
| Dec 31, 2023 | 100.00 Mn |
| Sep 30, 2023 | 100.00 Mn |
| Mar 31, 2023 | 100.00 Mn |
| Dec 31, 2022 | 162,000.00 |
| Sep 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 99.97 Mn |
| Mar 31, 2022 | 99.96 Mn |
| Dec 31, 2021 | 211,000.00 |
| Sep 30, 2021 | 99.93 Mn |
| Jun 30, 2021 | 99.92 Mn |
| Mar 31, 2021 | 245,000.00 |